BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 23070749)

  • 1. Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals.
    Gillis J; Cooper C; Rourke S; Rueda S; O'Brien K; Collins E; Rachlis A; Hart TA; Raboud J;
    Qual Life Res; 2013 Sep; 22(7):1525-35. PubMed ID: 23070749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
    Boyd A; Lacombe K; Miailhes P; Gozlan J; Bonnard P; Molina JM; Lascoux-Combe C; Serfaty L; Gault E; Desvarieux M; Girard PM
    J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana.
    Sagoe KW; Agyei AA; Ziga F; Lartey M; Adiku TK; Seshi M; Arens MQ; Mingle JA
    J Med Virol; 2012 Jan; 84(1):6-10. PubMed ID: 22095533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.
    Otegbayo JA; Taiwo BO; Akingbola TS; Odaibo GN; Adedapo KS; Penugonda S; Adewole IF; Olaleye DO; Murphy R; Kanki P
    Ann Hepatol; 2008; 7(2):152-6. PubMed ID: 18626434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival.
    Chen M; Wong WW; Law MG; Kiertiburanakul S; Yunihastuti E; Merati TP; Lim PL; Chaiwarith R; Phanuphak P; Lee MP; Kumarasamy N; Saphonn V; Ditangco R; Sim BL; Nguyen KV; Pujari S; Kamarulzaman A; Zhang F; Pham TT; Choi JY; Oka S; Kantipong P; Mustafa M; Ratanasuwan W; Durier N; Chen YM
    PLoS One; 2016; 11(3):e0150512. PubMed ID: 26933963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sero-prevalence of Hepatitis B and C viral co-infections among HIV-1 infected ART-naïve individuals in Kumasi, Ghana.
    Boateng R; Mutocheluh M; Dompreh A; Obiri-Yeboah D; Odame Anto E; Owusu M; Narkwa PW
    PLoS One; 2019; 14(4):e0215377. PubMed ID: 31002687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals.
    Gillis J; Smieja M; Cescon A; Rourke SB; Burchell AN; Cooper C; Raboud JM;
    Antivir Ther; 2014; 19(3):309-17. PubMed ID: 24429380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon.
    Mbougua JB; Laurent C; Kouanfack C; Bourgeois A; Ciaffi L; Calmy A; Gwet H; Koulla-Shiro S; Ducos J; Mpoudi-Ngolé E; Molinari N; Delaporte E
    BMC Public Health; 2010 Mar; 10():105. PubMed ID: 20193053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication Inhibition of Hepatitis B Virus and Hepatitis C Virus in Co-Infected Patients in Chinese Population.
    Yu G; Chi X; Wu R; Wang X; Gao X; Kong F; Feng X; Gao Y; Huang X; Jin J; Qi Y; Tu Z; Sun B; Zhong J; Pan Y; Niu J
    PLoS One; 2015; 10(9):e0139015. PubMed ID: 26422607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
    Su S; Fairley CK; Sasadeusz J; He J; Wei X; Zeng H; Jing J; Mao L; Chen X; Zhang L
    J Med Virol; 2018 Mar; 90(3):518-525. PubMed ID: 29091279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia.
    van Griensven J; Phirum L; Choun K; Thai S; De Weggheleire A; Lynen L
    PLoS One; 2014; 9(2):e88552. PubMed ID: 24533106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B and C infections in HIV-1 and non-HIV infected pregnant women in the Brong-Ahafo Region, Ghana.
    Frempong MT; Ntiamoah P; Annani-Akollor ME; Owiredu WKBA; Addai-Mensah O; Owiredu EW; Adu-Gyasi D; Agyapong EO; Sallah L
    PLoS One; 2019; 14(7):e0219922. PubMed ID: 31323077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of unsafe medical practices and sexual behaviours in the hepatitis B and C syndemic and HIV co-infection in Rwanda: a cross-sectional study.
    Makuza JD; Nisingizwe MP; Rwema JOT; Dushimiyimana D; Habimana DS; Umuraza S; Serumondo J; Ngwije A; Semakula M; Gupta N; Nsanzimana S; Janjua NZ
    BMJ Open; 2020 Jul; 10(7):e036711. PubMed ID: 32660951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV and viral hepatitis co-infection in New York City, 2000-2010: prevalence and case characteristics.
    Prussing C; Chan C; Pinchoff J; Kersanske L; Bornschlegel K; Balter S; Drobnik A; Fuld J
    Epidemiol Infect; 2015 May; 143(7):1408-16. PubMed ID: 25170631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active co-infection with HBV and/or HCV in South African HIV positive patients due for cancer therapy.
    Musyoki AM; Msibi TL; Motswaledi MH; Selabe SG; Monokoane TS; Mphahlele MJ
    J Med Virol; 2015 Feb; 87(2):213-21. PubMed ID: 25156907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-infection of Hepatitis B and Hepatitis C among HIV-infected patients: A cross-sectional study from tertiary care hospital of eastern Nepal.
    Shrestha LB; Yadav GK; Pradhan S; Sharma A; Pandit T; Chhetry R; Khanal B
    PLoS One; 2022; 17(3):e0264791. PubMed ID: 35239716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-Related Quality of Life in HIV-Infected and At-Risk Women: The Impact of Illicit Drug Use and Hepatitis C on a Community Preference Weighted Measure.
    Aden B; Nosyk B; Wittenberg E; Schackman BR
    Med Decis Making; 2014 Aug; 34(6):800-8. PubMed ID: 24106234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of triple infection with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV) type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria.
    Forbi JC; Gabadi S; Alabi R; Iperepolu HO; Pam CR; Entonu PE; Agwale SM
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):535-7. PubMed ID: 17612776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
    Rockstroh JK; Peters L; Grint D; Soriano V; Reiss P; Monforte Ad; Beniowski M; Losso MH; Kirk O; Kupfer B; Mocroft A;
    J Hepatol; 2013 Aug; 59(2):213-20. PubMed ID: 23583272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of hepatitis B and C virus infections in HIV-infected patients.
    Phuangchoei P; Chotiyaputta W; Chayakulkeeree M
    J Med Assoc Thai; 2015 Mar; 98(3):226-31. PubMed ID: 25920291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.